After decades of conjecture, scientists have finally experimentally demonstrated that psilacetin serves as a prodrug of the psychedelic compound psilocin when administered to laboratory animals. This metabolic pathway is shown in Figure 1 below. Figure 1: Like psilocybin, psilacetin (4-AcO-DMT) is metabolized to psilocin in the body. Psychedelic Science Review previously summarized the…
